Published in Clinical Oncology Week, March 16th, 2009
"Treatment of T-cell leukemia Jurkat cells with 3 nM simaomicin alpha induced an increase in the number of cells in G(1) and a decrease in those in G(2)-M phase. Cell cycle aberrations induced by simaomicin alpha...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.